US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 15.470
  • +0.260+1.71%
Trading Nov 29 10:48 ET
1.58BMarket Cap-2838P/E (TTM)

Intellia Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Development of genome editing-based therapies36.28M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States36.28M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme ARK Portfolio
ARK Portfolio
Intraday+1.74%
Gene Editing
Gene Editing
Intraday+0.63%